Medpace Long Term Debt vs Net Debt Analysis

MEDP Stock

USD 337.75 4.07 1.19%

Medpace Holdings financial indicator trend analysis is infinitely more than just investigating Medpace Holdings recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medpace Holdings is a good investment. Please check the relationship between Medpace Holdings Long Term Debt and its Net Debt accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.

Long Term Debt vs Net Debt

Long Term Debt vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medpace Holdings Long Term Debt account and Net Debt. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Medpace Holdings' Long Term Debt and Net Debt is 0.91. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Net Debt in the same time period over historical financial statements of Medpace Holdings, assuming nothing else is changed. The correlation between historical values of Medpace Holdings' Long Term Debt and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Medpace Holdings are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Long Term Debt i.e., Medpace Holdings' Long Term Debt and Net Debt go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Long Term Debt

Long-term debt is a debt that Medpace Holdings has held for over one year. Long-term debt appears on Medpace Holdings balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Medpace Holdings balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Most indicators from Medpace Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medpace Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.As of 11/22/2024, Sales General And Administrative To Revenue is likely to grow to 0.13, while Selling General Administrative is likely to drop slightly above 91.4 M.

	2021	2022	2023	2024 (projected)
Gross Profit	328.2M	432.4M	524.5M	278.6M
Total Revenue	1.1B	1.5B	1.9B	2.0B

Gross Profit Total Revenue

Medpace Holdings fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets
Common Stock Shares Outstanding		-0.39	0.18	-0.62	-0.63	0.0	0.21	0.18	-0.37	-0.63	0.21	0.49	-0.32	-0.1	-0.51	-0.64	-0.41	0.25	-0.1	-0.44	0.66	0.49	0.29	0.17	0.3	-0.18
Total Assets	-0.39		-0.49	0.78	0.79	0.54	-0.31	0.42	0.91	0.81	-0.69	-0.02	0.74	0.85	0.67	0.8	0.74	-0.5	0.85	0.81	-0.42	-0.32	-0.45	-0.42	-0.45	0.87
Short Long Term Debt Total	0.18	-0.49		-0.48	-0.64	-0.78	0.78	-0.81	-0.67	-0.64	0.93	0.03	-0.85	-0.52	0.21	-0.57	-0.58	0.98	-0.52	-0.72	0.36	-0.36	0.77	0.99	0.77	-0.7
Other Current Liab	-0.62	0.78	-0.48		0.94	0.3	-0.48	0.13	0.8	0.94	-0.57	-0.5	0.72	0.49	0.66	0.94	0.8	-0.56	0.49	0.77	-0.8	-0.48	-0.44	-0.45	-0.45	0.64
Total Current Liabilities	-0.63	0.79	-0.64	0.94		0.38	-0.57	0.26	0.86	1.0	-0.68	-0.5	0.85	0.49	0.54	0.99	0.79	-0.71	0.49	0.89	-0.77	-0.43	-0.57	-0.62	-0.57	0.69
Total Stockholder Equity	0.0	0.54	-0.78	0.3	0.38		-0.56	0.92	0.5	0.4	-0.91	0.53	0.56	0.83	-0.19	0.35	0.47	-0.72	0.83	0.41	-0.22	0.46	-0.58	-0.73	-0.58	0.77
Other Liab	0.21	-0.31	0.78	-0.48	-0.57	-0.56		-0.58	-0.48	-0.57	0.74	0.2	-0.65	-0.31	0.23	-0.55	-0.34	0.86	-0.31	-0.57	0.45	-0.31	0.58	0.84	0.58	-0.49
Net Tangible Assets	0.18	0.42	-0.81	0.13	0.26	0.92	-0.58		0.5	0.28	-0.86	0.49	0.61	0.7	-0.36	0.21	0.39	-0.75	0.7	0.42	0.06	0.63	-0.59	-0.79	-0.59	0.75
Property Plant And Equipment Net	-0.37	0.91	-0.67	0.8	0.86	0.5	-0.48	0.5		0.87	-0.74	-0.24	0.93	0.69	0.52	0.83	0.83	-0.7	0.69	0.94	-0.38	-0.21	-0.56	-0.63	-0.57	0.89
Current Deferred Revenue	-0.63	0.81	-0.64	0.94	1.0	0.4	-0.57	0.28	0.87		-0.7	-0.47	0.85	0.52	0.55	0.99	0.79	-0.71	0.52	0.89	-0.77	-0.43	-0.57	-0.62	-0.57	0.71
Net Debt	0.21	-0.69	0.93	-0.57	-0.68	-0.91	0.74	-0.86	-0.74	-0.7		-0.16	-0.82	-0.78	0.03	-0.64	-0.66	0.91	-0.78	-0.72	0.43	-0.25	0.71	0.89	0.71	-0.85
Retained Earnings	0.49	-0.02	0.03	-0.5	-0.5	0.53	0.2	0.49	-0.24	-0.47	-0.16		-0.3	0.46	-0.36	-0.49	-0.23	0.15	0.46	-0.4	0.46	0.55	0.14	0.09	0.14	0.14
Accounts Payable	-0.32	0.74	-0.85	0.72	0.85	0.56	-0.65	0.61	0.93	0.85	-0.82	-0.3		0.57	0.23	0.8	0.78	-0.88	0.57	0.95	-0.4	-0.05	-0.7	-0.84	-0.7	0.83
Cash	-0.1	0.85	-0.52	0.49	0.49	0.83	-0.31	0.7	0.69	0.52	-0.78	0.46	0.57		0.31	0.5	0.57	-0.48	1.0	0.53	-0.22	0.06	-0.42	-0.44	-0.42	0.87
Non Current Assets Total	-0.51	0.67	0.21	0.66	0.54	-0.19	0.23	-0.36	0.52	0.55	0.03	-0.36	0.23	0.31		0.6	0.45	0.15	0.31	0.42	-0.38	-0.78	0.04	0.27	0.04	0.32
Non Currrent Assets Other	-0.64	0.8	-0.57	0.94	0.99	0.35	-0.55	0.21	0.83	0.99	-0.64	-0.49	0.8	0.5	0.6		0.71	-0.65	0.5	0.87	-0.77	-0.47	-0.54	-0.55	-0.54	0.67
Other Assets	-0.41	0.74	-0.58	0.8	0.79	0.47	-0.34	0.39	0.83	0.79	-0.66	-0.23	0.78	0.57	0.45	0.71		-0.62	0.57	0.72	-0.53	-0.25	-0.51	-0.54	-0.51	0.78
Long Term Debt	0.25	-0.5	0.98	-0.56	-0.71	-0.72	0.86	-0.75	-0.7	-0.71	0.91	0.15	-0.88	-0.48	0.15	-0.65	-0.62		-0.48	-0.77	0.44	-0.28	0.78	0.99	0.78	-0.7
Cash And Short Term Investments	-0.1	0.85	-0.52	0.49	0.49	0.83	-0.31	0.7	0.69	0.52	-0.78	0.46	0.57	1.0	0.31	0.5	0.57	-0.48		0.53	-0.22	0.06	-0.42	-0.44	-0.42	0.87
Net Receivables	-0.44	0.81	-0.72	0.77	0.89	0.41	-0.57	0.42	0.94	0.89	-0.72	-0.4	0.95	0.53	0.42	0.87	0.72	-0.77	0.53		-0.46	-0.25	-0.62	-0.71	-0.62	0.75
Good Will	0.66	-0.42	0.36	-0.8	-0.77	-0.22	0.45	0.06	-0.38	-0.77	0.43	0.46	-0.4	-0.22	-0.38	-0.77	-0.53	0.44	-0.22	-0.46		0.5	0.31	0.35	0.31	-0.25
Common Stock Total Equity	0.49	-0.32	-0.36	-0.48	-0.43	0.46	-0.31	0.63	-0.21	-0.43	-0.25	0.55	-0.05	0.06	-0.78	-0.47	-0.25	-0.28	0.06	-0.25	0.5		-0.21	-0.37	-0.21	0.05
Short Term Investments	0.29	-0.45	0.77	-0.44	-0.57	-0.58	0.58	-0.59	-0.56	-0.57	0.71	0.14	-0.7	-0.42	0.04	-0.54	-0.51	0.78	-0.42	-0.62	0.31	-0.21		0.74	1.0	-0.58
Non Current Liabilities Total	0.17	-0.42	0.99	-0.45	-0.62	-0.73	0.84	-0.79	-0.63	-0.62	0.89	0.09	-0.84	-0.44	0.27	-0.55	-0.54	0.99	-0.44	-0.71	0.35	-0.37	0.74		0.74	-0.66
Inventory	0.3	-0.45	0.77	-0.45	-0.57	-0.58	0.58	-0.59	-0.57	-0.57	0.71	0.14	-0.7	-0.42	0.04	-0.54	-0.51	0.78	-0.42	-0.62	0.31	-0.21	1.0	0.74		-0.58
Other Current Assets	-0.18	0.87	-0.7	0.64	0.69	0.77	-0.49	0.75	0.89	0.71	-0.85	0.14	0.83	0.87	0.32	0.67	0.78	-0.7	0.87	0.75	-0.25	0.05	-0.58	-0.66	-0.58

Click cells to compare fundamentals

Medpace Holdings Account Relationship Matchups

Medpace Holdings fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	37.6M	37.7M	37.7M	33.7M	31.8M	29.0M
Total Assets	1.1B	1.4B	1.7B	1.4B	1.7B	1.3B
Short Long Term Debt Total	45.2M	115.1M	131.0M	188.9M	142.1M	173.9M
Other Current Liab	19.0M	157.9M	186.9M	238.4M	333.4M	350.1M
Total Current Liabilities	343.0M	440.1M	557.2M	803.5M	925.1M	971.4M
Total Stockholder Equity	726.3M	805.8M	952.9M	386.4M	559.0M	654.5M
Other Liab	28.6M	29.6M	18.8M	23.8M	21.4M	20.0M
Net Tangible Assets	9.5M	96.9M	249.2M	(314.0M)	(361.1M)	(379.2M)
Property Plant And Equipment Net	99.4M	198.8M	222.7M	248.9M	265.4M	138.1M
Current Deferred Revenue	192.4M	255.7M	344.6M	462.7M	559.9M	587.9M
Net Debt	(86.7M)	(162.6M)	(330.3M)	160.6M	(103.3M)	(98.2M)
Retained Earnings	68.1M	115.2M	235.0M	(359.8M)	(221.6M)	(210.6M)
Accounts Payable	22.4M	26.6M	25.7M	33.1M	31.9M	21.9M
Cash	131.9M	277.8M	461.3M	28.3M	245.4M	143.1M
Non Current Assets Total	826.0M	917.0M	969.0M	1.0B	1.1B	1.0B
Non Currrent Assets Other	9.5M	8.8M	17.4M	21.1M	25.0M	26.2M
Other Assets	9.9M	123.1M	42.6M	69.2M	79.6M	83.6M
Cash And Short Term Investments	131.9M	277.8M	461.3M	28.3M	245.4M	143.1M
Net Receivables	155.7M	161.0M	186.4M	253.4M	298.4M	163.0M
Common Stock Total Equity	355K	356K	360K	309K	278.1K	279.2K
Liabilities And Stockholders Equity	1.1B	1.4B	1.7B	1.4B	1.7B	1.3B
Non Current Liabilities Total	73.8M	144.8M	149.8M	162.6M	172.7M	182.2M
Other Current Assets	29.4M	69.8M	86.4M	52.3M	50.0M	40.7M
Other Stockholder Equity	660.6M	690.3M	722.4M	758.3M	790.4M	699.5M
Total Liab	416.8M	584.9M	707.0M	966.1M	1.1B	685.5M
Deferred Long Term Liab	12.8M	13.6M	1.1M	1.1M	1.2M	1.2M
Property Plant And Equipment Gross	99.4M	198.8M	222.7M	248.9M	344.8M	362.0M
Total Current Assets	317.0M	473.7M	690.9M	334.0M	593.8M	338.7M
Accumulated Other Comprehensive Income	(2.7M)	(131K)	(4.8M)	(12.4M)	(10.1M)	(9.6M)
Short Term Debt	109.3M	134.4M	159.3M	69.3M	293.0M	307.6M
Intangible Assets	54.4M	46.5M	41.4M	38.0M	35.8M	34.0M
Common Stock	355K	356K	360K	309K	308K	275.9K
Property Plant Equipment	99.4M	85.0M	93.2M	109.8M	126.3M	74.3M
Capital Surpluse	666.6M	695.9M	727.9M	770.8M	886.4M	714.1M

Pair Trading with Medpace Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medpace Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving against Medpace Stock

0.43	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.38	AQB	AquaBounty Technologies	Pair Corr
0.37	EWTX	Edgewise Therapeutics	Pair Corr
0.37	FLGC	Flora Growth Corp	Pair Corr
0.36	VRDN	Viridian Therapeutics	Pair Corr

The ability to find closely correlated positions to Medpace Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medpace Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medpace Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medpace Holdings to buy it.

The correlation of Medpace Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medpace Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medpace Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Medpace Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Medpace Stock Analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC